Markets


Valeant Pharmaceuticals Intl Inc’s (VRX) Bausch + Lomb Launches Biotrue ONEday in Europe

Bausch + Lomb, a division of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), announced the introduction of Biotrue® ONEday for Astigmatism daily disposable contact lenses in 20 …

General Electric Company (GE) Fuel-Efficient Marine Technology Powers Maersk’s World’s Largest Container Vessels

General Electric Company (NYSE:GE) Marine Solutions recently delivered its power take off/power take in (PTO/PTI) solution along with its Power Management System digital …

Company Update (NASDAQ:AMD): Advanced Micro Devices, Inc Introduces the Embedded Radeon E9170 Series GPU

Advanced Micro Devices, Inc. (NASDAQ:AMD) announced the AMD Embedded Radeon™ E9170 Series graphics processing unit (GPU).

“Izzy” Englander Gets More Confident on Endocyte, Inc. (ECYT), Ducks Out from Valeant Pharmaceuticals Intl Inc (VRX)

The hedge fund guru’s Q2 moves added ECYT gains to his pocket while saving him greater losses in VRX.

Company Update (NASDAQ:TSLA): Tesla Inc Provides 3Q:17 Vehicle Deliveries and Production Update

In Q3, Tesla Inc (NASDAQ:TSLA) delivered 26,150 vehicles, of which 14,065 were Model S, 11,865 were Model X, and 220 were Model 3. This …

Rigel Pharmaceuticals, Inc. (RIGL) Says FDA Not Planning an AdCom for Fostamatinib NDA; Shares Jump 30%

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) investors have a smile on their faces Monday morning, after the drug maker announced that the FDA is currently …

Louise Chen Bucks Odds on Valeant Pharmaceuticals Intl Inc (VRX) to Beat the Street Long-Term, Hedges Bet on Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

A glimpse into why Louise Chen believes Valeant is the better biotech play than Teva down the line.

xG Technology Inc (XGTI) Adds Regional Sales Manager for Unmanned and Autonomous Systems

xG Technology Inc (NASDAQ:XGTI) announced that Eric Haney has joined its IMT Vislink operations as Regional Sales Manager for Unmanned and Autonomous Systems. …

Sophiris Bio Inc. (SPHS) Shines Light on Topsalysin Phase 2b Enrollment in Localized Prostate Cancer

Sophiris Bio Inc (NASDAQ:SPHS) provided an update on clinical trial enrollment of its Phase 2b study of topsalysin as a treatment for men …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts